In prostate cancer, rectal cancer, glioma, melanoma, medulloblastoma, acute myeloid leukaemia and other cancer types, high OCT4 mRNA or protein expression was related with poor clinical outcomes (Mohiuddin et al., 2020). This evidence concerns the gene POU5F1 and Familial prostate cancer.